SCHEDULE: Morgan Stanley Discloses 5.8% Stake in Tactile Systems

Sentiment:

Beneficial Ownership Amendment


Morgan Stanley and its subsidiary have filed an amended Schedule 13G, disclosing a beneficial ownership of 5.8% in Tactile Systems Technology Inc.

Summary

  • Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in TACTILE SYSTEMS TECHNOLOGY INC.
  • Morgan Stanley beneficially owns an aggregate of 1,293,289 shares of Common Stock, representing 5.8% of the class.
  • Morgan Stanley Capital Services LLC beneficially owns an aggregate of 1,154,700 shares of Common Stock, representing 5.2% of the class.
  • Morgan Stanley holds shared voting power over 1,208,007 shares and shared dispositive power over 1,293,289 shares.
  • Morgan Stanley Capital Services LLC holds shared voting power over 1,154,700 shares and shared dispositive power over 1,154,700 shares.
  • The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as moderately positive. While a Schedule 13G is a factual disclosure, a significant stake by a reputable institution like Morgan Stanley can signal confidence in the issuer's value proposition, potentially attracting further investor interest.

Positives

  • A significant stake by a major financial institution like Morgan Stanley can be interpreted as a vote of confidence in Tactile Systems Technology Inc.'s long-term prospects and stability.

Future Outlook

NA

Management Comments

  • The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that institutional filings like this Schedule 13G provide transparency into significant ownership stakes by major financial players. Morgan Stanley's disclosure of a 5.8% stake in Tactile Systems Technology Inc., a company operating in the medical technology sector, indicates a notable institutional presence in the company's shareholder base. This type of filing is a standard regulatory requirement for investors crossing certain ownership thresholds.

Stakeholder Impact

  • Shareholders: The disclosure of a significant institutional holder may influence investor perception and potentially increase confidence in the stock.
  • Company Management: Awareness of a major institutional investor's stake may influence strategic decisions, though the filing states no intent to influence control.

Key Dates

DateDescription
12/31/2025Date of event which requires filing of this statement
02/12/2026Filing date of the Schedule 13G Amendment No. 1

Keywords

Tactile Systems Technology, Morgan Stanley, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investment, Medical Technology

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.